Skip to content
Screener

SELLAS Life Sciences Group, Inc. SLS Q2 2026 earnings

Reported August 11, 2026 · After market close

EPS-$0.05Miss by $0.01
EPS estimate-$0.05

Next report

Nov 11, 2026 (in 2 months)
EPS estimate-$0.05

Financials

Q2 2026

Income statement

See full
Operating income-$10.6M-54.6%
Net income-$9.6M-45.5%
EPS (diluted)-$0.05+28.6%

Balance sheet

See full
Cash & equivalents$138.3M+447%
Total debt$737.0K0.0%
Total equity$137.7M+426%
Total assets$145.4M+350%

Cash flow

See full
Operating cash flow-$7.6M-3.5%

Valuation & ratios

Valuation

as of 08/27/26
See full
Market cap$2.77B+1,271%
Enterprise value$2.64B+1,384%

Returns & leverage

See full
Return on equity-39.6%-17.4pp
Debt / equity0×0.0×
Current ratio18.8×+13.9×

FAQ

When did SELLAS Life Sciences Group, Inc. report Q2 2026 earnings?
SELLAS Life Sciences Group, Inc. (SLS) reported Q2 2026 earnings on August 11, 2026 after market close.
What were SELLAS Life Sciences Group, Inc.'s Q2 2026 revenue and EPS?
SELLAS Life Sciences Group, Inc. reported eps of $-0.05 for Q2 2026.
Did SELLAS Life Sciences Group, Inc. beat estimates in Q2 2026?
EPS missed the consensus estimate of $-0.04 by $0.01.
How did SELLAS Life Sciences Group, Inc.'s Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 28.6% from $-0.07.
Where can I find SELLAS Life Sciences Group, Inc.'s Q2 2026 SEC filings?
You can read the 8-K earnings release (0001390478-26-000013) and the 10-Q periodic report (0001390478-26-000012) directly on SEC EDGAR. The filing index links above go to sec.gov.